DFTXDefinium Therapeutics, Inc.

$43.79

What is the market doing?

What the tape says about DFTX

Definium Therapeutics, Inc. is +338% over the past year while the S&P 500 is +23%: 316 points ahead of the market.

+338%

1-year return · S&P 500 +23%

vs 200-day average
+99%

vs 200-day average · a clear uptrend

RSI (14)
44

RSI (14) · neutral

Below its 52-week high
−7.0%

Below its 52-week high

2024-08-06$4.89 – $47.08 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$43.79
1 monthS&P 500 +3.7%
+2.0%
1 yearS&P 500 +23%
+338%
5 yearsS&P 500 +87%
−4.9%
vs 50-day average$37.72
+16%
52-week high
$47.08
52-week low
$8.88
Annualised volatility
78%
Calendar-year price return
YearReturn
2026 (year to date)+227%
2025+92%
2024+90%
2023+66%
2022−89%
2021−55%
2020+5346%
2019+27%
2018−85%
2017−46%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+6.4%
Feb107 of 10+10.0%
Mar105 of 10+104%
Apr106 of 10+2.0%
May103 of 10−3.5%
Jun105 of 10−0.47%
Jul104 of 10−2.4%
Aug105 of 10+36%
Sep93 of 9−4.2%
Oct96 of 9+5.0%
Nov93 of 9+6.8%
Dec106 of 10+11%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.